Early phase clinical development is essential to the overall drug R&D. The value of R&D won’t be maximized without higher success rates of clinical trials and lower costs. Theaking correct strategies and tactics are the guarantee of a successful drug development, which is you must know. This course, beginning with the macro strategies of the clinical design, taking the examples of oncology/non-oncology clinical trials, explains the phase I, statistics and the first-in-human (FIH), as well as the Proof of Concept (PoC) to transition to phase III, and gives tactical guidance on the operational level with more practices.

For More Details, Please see: https://www.diahome.org/en/course-listing/training/2019/03/early-phase-clinical-development-workshop